相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Emicizumab state-of-the-art update
Johnny Mahlangu et al.
HAEMOPHILIA (2022)
Heterogeneous coagulant potential of emicizumab in neonatal factor VIII-deficient plasma
Masahiro Takeyama et al.
PEDIATRIC BLOOD & CANCER (2022)
Pharmacokinetics and Pharmacodynamics of Emicizumab in Persons with Hemophilia A with Factor VIII Inhibitors: HAVEN 1 Study
Christophe Schmitt et al.
THROMBOSIS AND HAEMOSTASIS (2021)
Comparison of different activators of coagulation by turbidity analysis of hereditary dysfibrinogenemia and controls
Rita Marchi et al.
BLOOD COAGULATION & FIBRINOLYSIS (2021)
Comparison of bypassing agents in patients on emicizumab using global hemostasis assays
Hande Kizilocak et al.
HAEMOPHILIA (2021)
Exploratory in vitro evaluation of thrombin generation of eptacog beta (recombinant human fviia) and emicizumab in congenital haemophilia A plasma
Jerry Grandoni et al.
HAEMOPHILIA (2021)
Emicizumab prophylaxis: Prospective longitudinal real-world follow-up and monitoring
Assaf A. Barg et al.
HAEMOPHILIA (2021)
Real-World Data on Bleeding Patterns of Hemophilia A Patients Treated with Emicizumab
Sarina Levy-Mendelovich et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Determining the approximate factor VIII level of patients with severe haemophilia A on emicizumab using in vivo global haemostasis assays
Hande Kizilocak et al.
HAEMOPHILIA (2021)
Prediction of the haemostatic effects of bypassing therapy using comprehensive coagulation assays in emicizumab prophylaxis-treated haemophilia A patients with inhibitors
Shoko Furukawa et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Emicizumab improves the stability and structure of fibrin clot derived from factor VIII-deficient plasma, similar to the addition of factor VIII
Naruto Shimonishi et al.
HAEMOPHILIA (2020)
Emicizumab treatment and monitoring in a paediatric cohort: real-world data
Assaf A. Barg et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Laboratory monitoring of hemophilia A treatments: new challenges
Peter J. Lenting
BLOOD ADVANCES (2020)
Rescue factor VIII replacement to secure hemostasis in a patient with hemophilia A and inhibitors on emicizumab prophylaxis undergoing hip replacement
Elena Santagostino et al.
HAEMATOLOGICA (2019)
Use of global assays to monitor emicizumab prophylactic therapy in patients with haemophilia A with inhibitors
Donald F. Brophy et al.
HAEMOPHILIA (2019)
Intrinsic differences between FVIIIa mimetic bispecific antibodies and FVIII prevent assignment of FVIII-equivalence
Nina C. Leksa et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
Effects and Interferences of Emicizumab, a Humanised Bispecific Antibody Mimicking Activated Factor VIII Cofactor Function, on Coagulation Assays
Joanne Adamkewicz et al.
THROMBOSIS AND HAEMOSTASIS (2019)
Global coagulation function assessed by rotational thromboelastometry predicts coagulation-steady state in individual hemophilia A patients receiving emicizumab prophylaxis
Koji Yada et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2019)
Efficacy, safety, and pharmacokinetics of emicizumab prophylaxis given every 4 weeks in people with haemophilia A (HAVEN 4): a multicentre, open-label, non-randomised phase 3 study
Steven W. Pipe et al.
LANCET HAEMATOLOGY (2019)
A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors
Guy Young et al.
BLOOD (2019)
Spotlight on emicizumab in the management of hemophilia A: patient selection and special considerations
Koji Yada et al.
JOURNAL OF BLOOD MEDICINE (2019)
Management of perioperative hemostasis in a severe hemophilia A patient with inhibitors on emicizumab using global hemostasis assays
Hande Kizilocak et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2019)
Use of thrombin generation assay to personalize treatment of breakthrough bleeds in a patient with hemophilia and inhibitors receiving prophylaxis with emicizumab
Yesim Dargaud et al.
HAEMATOLOGICA (2018)
Modified clot waveform analysis to measure plasma coagulation potential in the presence of the anti-factor IXa/factor X bispecific antibody emicizumab
K. Nogami et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
In vitro studies show synergistic effects of a procoagulant bispecific antibody and bypassing agents
R. Hartmann et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Thrombodynamics, a new global coagulation test: Measurement of heparin efficiency
Elena I. Sinauridze et al.
TALANTA (2018)
A contemporary look at FVIII inhibitor development: still a great influence on the evolution of hemophilia therapies
Elena Santagostino et al.
EXPERT REVIEW OF HEMATOLOGY (2018)
Use of thrombin generation assay to personalize treatment of breakthrough bleeds in a patient with hemophilia and inhibitors receiving prophylaxis with emicizumab
Yesim Dargaud et al.
HAEMATOLOGICA (2018)
Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors
J. Mahlangu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
A Pharmacometric Approach to Substitute for a Conventional Dose-Finding Study in Rare Diseases: Example of Phase III Dose Selection for Emicizumab in Hemophilia A
Koichiro Yoneyama et al.
CLINICAL PHARMACOKINETICS (2018)
Development of Shiny app tools to simplify and standardize the analysis of hemostasis assay data: communication from the SSC of the ISTH
C. Longstaff
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Emicizumab Prophylaxis in Hemophilia A with Inhibitors
Johannes Oldenburg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Emicizumab, a bispecific antibody recognizing coagulation factors IX and X: how does it actually compare to factor VIII?
Peter J. Lenting et al.
BLOOD (2017)
Factor VIII-Mimetic Function of Humanized Bispecific Antibody in Hemophilia A
Midori Shima et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
An international study on the standardization of fibrin clot permeability measurement: methodological considerations and implications for healthy control values
M. PIETERS et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model
Takehisa Kitazawa et al.
NATURE MEDICINE (2012)
Monitoring thrombin generation: Is addition of corn trypsin inhibitor needed?
Henri M. H. Spronk et al.
THROMBOSIS AND HAEMOSTASIS (2009)
Thrombin generation and fibrin clot structure
Alisa S. Wolberg
BLOOD REVIEWS (2007)
Calibrated automated thrombin generation measurement in clotting plasma
HC Hemker et al.
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS (2003)
分享论文
